Double-blind, placebo-controlled trial of daunorubicin and cytarabine with or without recombinant human granulocyte colony-stimulating factor in elderly patients with acute myeloid leukemia: economic evaluation with attention to inpatient and outpatient resource utilization.
作者信息
Freund D A, Dittus R S
机构信息
School of Public and Environmental Affairs, Department of Medicine and Family Medicine, Bowen Research Center, Indiana University, Bloomington 47405, USA.
出版信息
J Natl Cancer Inst Monogr. 1995(19):37-40.
PMID:7577203
Abstract
摘要
Zotero 插件